1367P Treatment duration and adherence in ALK+ non-small cell lung cancer patients treated with brigatinib following prior ALK TKI therapy in the US
| Autor: | Lin, H.M., Wu, Y., Gorritz, M., McGuiness, C., Huang, W-T., Chen, C-C., Jahanzeb, M. |
|---|---|
| Zdroj: | In Annals of Oncology September 2020 31 Supplement 4:S873-S874 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|